Skip to main content
. Author manuscript; available in PMC: 2018 May 30.
Published in final edited form as: Circulation. 2017 Mar 30;135(22):2119–2132. doi: 10.1161/CIRCULATIONAHA.117.027272

Table 4.

Change in risk prediction metrics with additional of test results to base models

MESA DHS
C-statistic Base Model* C-statistic Base Model + Test Results Category free NRI IDI C-statistic Base Model* C-statistic Base Model + Test Results Category free NRI IDI
Global CVD 0.743 0.786 0.473 (0.383,0.563) 0.073 (0.063, 0.083) 0.832 0.850 0.261 (0.052,0.47) 0.024 (0.008, 0.04)
ASCVD 0.748 0.779 0.394 (0.275,0.512) 0.042 (0.032, 0.052) 0.859 0.873 0.355 (0.129,0.581) 0.021 (0.001, 0.041)
CHD 0.749 0.794 0.498 (0.357,0.638) 0.043 (0.031, 0.055) 0.865 0.889 0.585 (0.294,0.877) 0.058 (0.023, 0.093)
Heart Failure 0.786 0.847 0.549 (0.407,0.692) 0.086 (0.064, 0.108) 0.840 0.871§ 0.719 (0.381,0.989) 0.13 (0.042, 0.218)
All-Cause Mortality 0.746 0.789 0.315 (0.199,0.431) 0.038 (0.03, 0.046) 0.817 0.829 0.061 (−0.516,0.638) 0.03 (0.005, 0.055)
Cardiovascular Mortality 0.822 0.840 0.438 (0.185,0.691) 0.05 (0.032, 0.068) 0.840 0.858 0.308 (−0.045,0.662) 0.012 (−0.01, 0.034)
*

Base model includes variables in the pooled cohort equations plus statin therapy. Global CVD models additionally include creatinine and heart failure models additionally include body mass index and creatinine. Coefficients were determined separately for each model.

p<0.001;

p<0.01;

§

p<0.05 vs. base model